OLYMPIA — For the third year in a row, Democratic state lawmakers are pushing a measure that would require Washington insurers offering maternity care to also cover elective abortions, but as in the past, it’s likely to hit a roadblock in the Senate.
In a public hearing Monday held just hours after the start of the legislative session, the state House’s Health Care and Wellness Committee heard arguments from both sides of the debate. Opponents of the abortion insurance law have long argued that it’s unnecessary since all the plans in the state had, up until the new health care law took effect this year, been providing abortion coverage. Advocates have pointed to confusion from new rules that create more administrative burdens for insurers when they cover abortions.
A longstanding federal provision known as the Hyde amendment prohibits the use of federal funds to pay for abortion except in cases of rape, incest or to save the life of the mother, and insurers on the exchange have to create separate accounts that segregate premium payments for abortion services from premiums for everything else. Some states have banned abortion coverage for plans being sold on the exchanges, which are a centerpiece of the federal Affordable Care Act. Washington’s law, if passed, would be the first in the nation to require abortion coverage.
Stephanie Marquis, a spokeswoman with the Washington State Office of the Insurance Commissioner, said that the federal accounting requirement has created some complications for insurers, but that currently, all plans but those offered by two companies offer full coverage for abortion services under the new health exchange. Group Health isn’t covering abortion through its plans being offered on the marketplace, but Marquis said women will still be able to access the service at Group Health facilities. Kaiser Foundation Health Plan of The Northwest will cover elective surgical abortion, but Marquis said its current plans don’t cover prescriptions for drug-induced abortions. A spokesman for Kaiser said, however, that it will still provide access to abortion-inducing drugs.